KUALA LUMPUR, Feb 12 — In the weeks leading up to Chinese New Year and Ramadan, a familiar conversation plays out at aesthetic clinics — one increasingly shaped by social media.

As the festive season drives demand for quick weight-loss solutions, more walk-in patients are requesting Glucagon-like Peptide-1 (GLP-1) “slimming shots” they saw online, reflecting how social media hype has turned a prescription treatment for obesity and diabetes into what many now view as a lifestyle fix.